Y. Arai, S. Watanabe, M. Kimira, K. Shimoi, R. Mochizuki et al., Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration, J. Nutr, vol.130, pp.2243-2250, 2000.

P. Becher, Technique of emulsification,in: Emulsions: Theory and Practice, p.470, 1965.

M. Böhl, S. Tietze, A. Sokoll, S. Madathil, F. Pfennig et al., Flavonoids Affect Actin Functions in Cytoplasm and Nucleus, Biophysical Journal, vol.93, issue.8, pp.2767-2780, 2007.
DOI : 10.1529/biophysj.107.107813

I. Capek, Degradation of kinetically-stable o/w emulsions, Advances in Colloid and Interface Science, vol.107, issue.2-3, pp.125-155, 2004.
DOI : 10.1016/S0001-8686(03)00115-5

C. S. Chien, K. H. Shen, J. S. Huang, S. C. Ko, and Y. W. Shih, Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells, Molecular and Cellular Biochemistry, vol.61, issue.1-2, pp.169-180, 2010.
DOI : 10.1007/s11010-009-0217-z

A. Constantinou, R. Mehta, C. Runyan, K. Rao, A. Vaughan et al., Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships, Journal of Natural Products, vol.58, issue.2, pp.217-225, 1995.
DOI : 10.1021/np50116a009

A. A. Date and M. S. Nagarsenker, Parenteral microemulsions: An overview, International Journal of Pharmaceutics, vol.355, issue.1-2, pp.19-30, 2008.
DOI : 10.1016/j.ijpharm.2008.01.004

C. J. Edgell, C. C. Mcdonald, and J. B. Graham, Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3734-3737, 1983.
DOI : 10.1073/pnas.80.12.3734

A. G. Floyd, Top ten considerations in the development of parenteral emulsions, Pharmaceutical Science & Technology Today, vol.2, issue.4, 1999.
DOI : 10.1016/S1461-5347(99)00141-8

T. Fotsis, M. S. Pepper, E. Aktas, S. Breit, S. Rasku et al., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, vol.57, pp.2916-2921, 1997.

S. C. Gad, C. D. Cassidy, N. Aubert, B. Spainhour, and H. Robbe, Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species, International Journal of Toxicology, vol.36, issue.9, pp.499-521, 2006.
DOI : 10.1080/10915810600961531

S. Ganta, J. W. Paxton, B. C. Baguley, and S. Garg, Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion, International Journal of Pharmaceutics, vol.360, issue.1-2, pp.115-121, 2008.
DOI : 10.1016/j.ijpharm.2008.04.027

M. Gibaldi and D. Perrier, Noncompartmental Analysis Based on Statistical Moment Theory, pp.409-417, 1982.
DOI : 10.1201/b14095-12

M. Han, C. X. He, Q. L. Fang, X. C. Yang, Y. Y. Diao et al., A Novel Camptothecin Derivative Incorporated in Nano-Carrier Induced Distinguished Improvement in Solubility, Stability and Anti-tumor Activity Both In Vitro and In Vivo, Pharmaceutical Research, vol.3, issue.109, pp.926-935, 2009.
DOI : 10.1007/s11095-008-9795-9

B. H. Havsteen, The biochemistry and medical significance of the flavonoids, Pharmacology & Therapeutics, vol.96, issue.2-3, pp.67-202, 2002.
DOI : 10.1016/S0163-7258(02)00298-X

Z. Hu, R. Tawa, T. Konishi, N. Shibata, and K. Takada, A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin, Life Sciences, vol.69, issue.24, pp.2899-2910, 2001.
DOI : 10.1016/S0024-3205(01)01375-3

J. Jankun, S. H. Selman, J. Aniola, and E. Skrzypczak-jankun, Nutraceutical inhibitors of urokinase: Potential applications in prostate cancer prevention and treatment, Oncology Reports, vol.16, pp.341-346, 2006.
DOI : 10.3892/or.16.2.341

S. Kawakami, F. Yamashita, and M. Hashida, Disposition characteristics of emulsions and incorporated drugs after systemic or local injection, Advanced Drug Delivery Reviews, vol.45, issue.1, pp.77-88, 2000.
DOI : 10.1016/S0169-409X(00)00102-2

N. Khan, M. Asim, F. Afaq, Z. M. Abu, and H. Mukhtar, A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice, Cancer Research, vol.68, issue.20, pp.8555-8563, 2008.
DOI : 10.1158/0008-5472.CAN-08-0240

M. Kimira, Y. Arai, K. Shimoi, and S. Watanabe, Japanese Intake of Flavonoids and Isoflavonoids from Foods, Journal of Epidemiology, vol.8, issue.3, pp.168-175, 1998.
DOI : 10.2188/jea.8.168

T. R. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, International Journal of Pharmaceutics, vol.212, issue.2, pp.233-246, 2001.
DOI : 10.1016/S0378-5173(00)00614-1

G. Leonarduzzi, G. Testa, B. Sottero, P. Gamba, and G. Poli, Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids, Current Medicinal Chemistry, vol.17, issue.1, pp.74-95, 2010.
DOI : 10.2174/092986710789957760

M. Lopez-lazaro, Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002.
DOI : 10.2174/1568011023353714

H. Lu, D. J. Chang, B. Baratte, L. Meijer, and U. Schulze-gahmen, Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, Journal of Medicinal Chemistry, vol.48, issue.3, pp.737-743, 2005.
DOI : 10.1021/jm049353p

E. Middleton, . Jr, C. Kandaswami, and T. C. Theoharides, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, pp.673-751, 2000.

N. Mignet, J. Seguin, R. Romano, M. Brullé, L. Touil et al., Development of a liposomal formulation of the natural flavonoid fisetin, International Journal of Pharmaceutics, vol.423, issue.1, pp.69-76, 2012.
DOI : 10.1016/j.ijpharm.2011.04.066

R. H. Müller, S. Schmidt, I. Buttle, A. Akkar, J. Schmitt et al., SolEmulsnovel technology for the formulation of i.v. emulsions with poorly soluble drugs, Int. J, p.550, 2004.

Y. Nishioka and H. Yoshino, Lymphatic targeting with nanoparticulate system Adv, 2001.

A. O. Nornoo, D. W. Osborne, and D. S. Chow, Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis, Int. J. Pharm, vol.349, pp.555-108, 2008.

A. J. Olaharski, S. T. Mondrala, and D. A. Eastmond, Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.582, issue.1-2, pp.79-86, 2005.
DOI : 10.1016/j.mrgentox.2005.01.002

S. Poullain-termeau, S. Crauste-manciet, D. Brossard, S. Muhamed, G. Nicolaos et al., Effect of Oil-in-Water Submicron Emulsion Surface Charge on Oral Absorption of a Poorly Water-Soluble Drug in Rats, Drug Delivery, vol.50, issue.8, 2008.
DOI : 10.1016/S0378-4347(00)81271-2

P. R. Reddy and V. Venkateswarlu, Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion, Journal of Drug Targeting, vol.55, issue.13, pp.543-553, 2005.
DOI : 10.1248/cpb.42.646

D. K. Sarker, Engineering of Nanoemulsions for Drug Delivery, Current Drug Delivery, vol.2, issue.4, pp.297-310, 2005.
DOI : 10.2174/156720105774370267

D. Soma, J. Kitayama, H. Ishigami, S. Kaisaki, and H. Nagawa, Different Tissue Distribution of Paclitaxel With Intravenous and Intraperitoneal Administration, Journal of Surgical Research, vol.155, issue.1, pp.142-146, 2009.
DOI : 10.1016/j.jss.2008.06.049

R. G. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004.
DOI : 10.1023/B:PHAM.0000016235.32639.23